Bill > S06967

This bill directs the New York State Commissioner of Health to establish comprehensive regulations for medical providers treating patients with opioid use disorder, focusing on improving treatment quality and preventing medication misuse. The regulations require medical providers treating more than 50 patients with opiate misuse or addiction to implement several key practices, including providing patients with detailed, documented information about FDA-approved addiction medication options, offering patient education and informed consent, developing individualized treatment plans reviewed every six months, and providing treatment counseling. The bill mandates that if a patient chooses a medication not available with their current provider, the provider must refer them to a facility that can provide it. Additionally, providers must use state-approved assessment tools, inform patients about peer recovery support services, and implement diversion control practices such as limited medication prescriptions and toxicology screening. The bill requires the Commissioner to monitor medical providers' compliance with these regulations and establish penalties for non-compliance. These rules aim to promote recovery from opioid misuse, ensure patient education and choice, and reduce the potential diversion of addiction medications. The regulations will take effect on January 1, 2026, with preparatory rule-making authorized immediately.

Health and Social Services

https://www.nysenate.gov/legislation/bills/2025/S6967